Terms: = Head and neck cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Staging
31 results:
1. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
[No Abstract] [Full Text] [Related]
2. Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies.
Ruby L; Jayaprakasam VS; Fernandes MC; Paroder V
Hematol Oncol Clin North Am; 2024 Jun; 38(3):711-730. PubMed ID: 38575457
[TBL] [Abstract] [Full Text] [Related]
3. Retrospective analysis of treatment, including access to breast reconstructions, of breast cancer patients - war refugees from Ukraine in Poland - the experience of a single tertiary care institution.
Wow T; Murawa D; Boguszewska-Byczkiewicz K; Burzyński J; Ryk A; Kolacinska A
Pol Przegl Chir; 2023 Mar; 95(6):20-23. PubMed ID: 38058164
[TBL] [Abstract] [Full Text] [Related]
4. Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNIcancer, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR).
Veziant J; Bouché O; Aparicio T; Barret M; El Hajbi F; Lepilliez V; Lesueur P; Maingon P; Pannier D; Quero L; Raoul JL; Renaud F; Seitz JF; Serre AA; Vaillant E; Vermersch M; Voron T; Tougeron D; Piessen G; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2023 Dec; 55(12):1583-1601. PubMed ID: 37635055
[TBL] [Abstract] [Full Text] [Related]
5. This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients.
van Hemert AKE; van Duijnhoven FH; Vrancken Peeters MTFD
Breast; 2023 Oct; 71():89-95. PubMed ID: 37562108
[TBL] [Abstract] [Full Text] [Related]
6. CircMAN1A2 promotes vasculogenic mimicry of nasopharyngeal carcinoma cells through upregulating erbb2 via sponging miR-940.
Mo H; Shen J; Zhong Y; Chen Z; Wu T; Lv Y; Xie Y; Hao Y
Oncol Res; 2022; 30(4):187-199. PubMed ID: 37304410
[TBL] [Abstract] [Full Text] [Related]
7. Breast cancer Subtypes in Northern Thailand and Barriers to satisfactory survival outcomes.
Ditsatham C; Sripan P; Chaiwun B; Klunklin P; Tharavichitkul E; Chakrabandhu S; Muangwong P; Chitapanarux I
BMC Cancer; 2022 Nov; 22(1):1147. PubMed ID: 36348356
[TBL] [Abstract] [Full Text] [Related]
8. E2F4 transcription factor is a prognostic biomarker related to immune infiltration of head and neck squamous cell carcinoma.
Qi L; Ren Z; Li W
Sci Rep; 2022 Jul; 12(1):12132. PubMed ID: 35840663
[TBL] [Abstract] [Full Text] [Related]
9. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract] [Full Text] [Related]
10. Updates on World Health Organization classification and staging of esophageal tumors: implications for future clinical practice.
Lam AK
Hum Pathol; 2021 Feb; 108():100-112. PubMed ID: 33157124
[TBL] [Abstract] [Full Text] [Related]
11. Primary Tumor Location Is a Predictor of Poor Prognosis in Patients with Locally Advanced Esophagogastric cancer Treated with Perioperative Chemotherapy.
Felismino TC; de Oliveira ACF; Alves ACF; da Costa Junior WL; Coimbra FJF; de Souza Begnami MDF; Riechelmann RP; de Jesus VHF; de Mello CAL
J Gastrointest Cancer; 2020 Jun; 51(2):484-490. PubMed ID: 31179509
[TBL] [Abstract] [Full Text] [Related]
12. Salivary duct carcinoma: evaluation of treatment and outcome in a tertiary referral institute.
Beck ACC; Lohuis PJFM; Al-Mamgani A; Smit LA; Klop WMC
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1885-1892. PubMed ID: 29785551
[TBL] [Abstract] [Full Text] [Related]
13. Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma.
Narra RK; Alvarez Argote J; Mesologites T; Dasanu CA
Conn Med; 2015 Aug; 79(7):401-4. PubMed ID: 26411176
[TBL] [Abstract] [Full Text] [Related]
14. her2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison.
Koopman T; Smits MM; Louwen M; Hage M; Boot H; Imholz AL
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1343-51. PubMed ID: 25544671
[TBL] [Abstract] [Full Text] [Related]
15. A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Findlay JM; Middleton MR; Tomlinson I
Ann Oncol; 2015 Apr; 26(4):624-644. PubMed ID: 25214541
[TBL] [Abstract] [Full Text] [Related]
16. Clinical significance of the expression of EGFR signaling pathway-related proteins in esophageal squamous cell carcinoma.
Li JC; Zhao YH; Wang XY; Yang Y; Pan DL; Qiu ZD; Su Y; Pan JJ
Tumour Biol; 2014 Jan; 35(1):651-7. PubMed ID: 24052437
[TBL] [Abstract] [Full Text] [Related]
17. Predictors of cervical lymph node metastasis in salivary gland cancer.
Ettl T; Gosau M; Brockhoff G; Schwarz-Furlan S; Agaimy A; Reichert TE; Rohrmeier C; Zenk J; Iro H
Head Neck; 2014 Apr; 36(4):517-23. PubMed ID: 23780687
[TBL] [Abstract] [Full Text] [Related]
18. Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.
Al-Momani H; Barnes R; El-Hadi A; Shah R; Lewis WG; Edwards P
World J Gastroenterol; 2012 Nov; 18(44):6447-51; discussion p.6450. PubMed ID: 23197890
[TBL] [Abstract] [Full Text] [Related]
19. Changes and prognostic value of serum vascular endothelial growth factor in patients with differentiated thyroid cancer.
Zhou ZH; Cui XN; Xing HG; Yan RH; Yao DK; Wang LX
Med Princ Pract; 2013; 22(1):24-8. PubMed ID: 22890443
[TBL] [Abstract] [Full Text] [Related]
20. Current developments in the management of locally advanced esophageal cancer.
McNamara MJ; Adelstein DJ
Curr Oncol Rep; 2012 Aug; 14(4):342-9. PubMed ID: 22544559
[TBL] [Abstract] [Full Text] [Related]
[Next]
